Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01278212 · ClinicalTrials.gov registry record · NA
Accelerated Hypofractionated Radiotherapy (AHF-RT) for the Treatment of Breast Cancer
A NA study, sponsored by University of Louisville.
- Completed
- Registry status
- NA
- Development phase
- 158
- Enrollment target
NCT01278212 is a NA study that has completed, run by University of Louisville. The registered enrollment target is 158 participants.
The verdict
NCT01278212, a NA study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- NA
- Development phase
- 158 participants
- Enrollment target
Study Summary
The goal of this study is to explore the safety, effectiveness, quality of life, and cost effectiveness of accelerated hypofractionated radiotherapy (AHF-RT) as treatment after lumpectomy in patients with early stage breast cancer.
Interventions
- RADIATION accelerated hypofractionated radiotherapy (AHF-RT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2011-01 |
| Est. Completion | 2021-01-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01278212
The ClinicalTrials.gov registry entry for NCT01278212 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 158 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which accelerated hypofractionated radiotherapy (AHF-RT) is the first listed.
NCT01278212 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01278212 about?
NCT01278212 is a clinical study titled "Accelerated Hypofractionated Radiotherapy (AHF-RT) for the Treatment of Breast Cancer". The goal of this study is to explore the safety, effectiveness, quality of life, and cost effectiveness of accelerated hypofractionated radiotherapy (AHF-RT) as treatment after lumpectomy in patients with early stage breast cancer.
What is the current status of trial NCT01278212?
This trial is currently completed. It is a NA study. The enrollment target is 158 participants. The study started on 2011-01. Estimated completion is 2021-01-27.
What interventions are being tested in trial NCT01278212?
The interventions under investigation include: accelerated hypofractionated radiotherapy (AHF-RT) (RADIATION).
Who is sponsoring clinical trial NCT01278212?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.